Watch MET-PF. Know when insiders buy.
One email the day a filing lands. Free.
MET-PF
METLIFE INC
17.29
−0.06 −0.35%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $11BP/E 3.3DIV YIELD —FCF YIELD —REV TTM $79.4B +8.7%NET INCOME $3.6B −15.4%NET CASH $422M52W 16.95 – 21.19SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $19.2B | +10.5% | — | $1.6B | $736M | +1.0% | 1.09 | $2.2B | — | — | Aug 6 |
| Q1 2026 · Mar 31 | $19.1B | +2.7% | — | $1.6B | $1.2B | +25.4% | 1.74 | $2.7B | — | — | Aug 6 |
| Q4 2025 · Dec 31derived | $23.8B | +27.6% | — | $1.7B | $809M | −36.3% | 1.17 | $7.1B | — | — | Feb 19 |
| Q3 2025 · Sep 30 | $17.4B | −5.9% | — | $1.6B | $896M | −33.2% | 1.22 | $3.6B | — | — | Nov 7 |
| Q2 2025 · Jun 30 | $17.3B | −2.7% | — | $1.4B | $729M | −22.9% | 1.03 | $2.2B | — | — | Aug 6 |
| Q1 2025 · Mar 31 | $18.6B | +15.6% | — | $1.4B | $945M | +9.0% | 1.28 | $4.3B | — | — | Aug 6 |
| Q4 2024 · Dec 31derived | $18.7B | −1.9% | — | $1.5B | $1.3B | +109.4% | 1.77 | $4.6B | — | — | Feb 19 |
| Q3 2024 · Sep 30 | $18.4B | +16.2% | — | $1.4B | $1.3B | +174.4% | 1.81 | $4.2B | — | — | Nov 7 |
| Q2 2024 · Jun 30 | $17.8B | — | — | $1.7B | $946M | — | 1.28 | $3.5B | — | — | Nov 7 |
| Q1 2024 · Mar 31 | $16.1B | — | — | $1.4B | $867M | — | 1.10 | $2.3B | — | — | Aug 7 |
| Q4 2023 · Dec 31 | $19B | — | — | — | $607M | — | 0.77 | $5.2B | — | — | Feb 19 |
| Q3 2023 · Sep 30 | $15.9B | — | — | — | $489M | — | 0.56 | $3.5B | — | — | Nov 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $77.1B | — | $6.1B | $3.4B | 4.4% | 4.71 | $17.1B | — | — | $2.9B | $1.5B |
| FY2024 · to Dec 31 | $71B | — | $6B | $4.4B | 6.2% | 5.94 | $14.6B | — | — | $3.2B | $1.5B |
| FY2023 · to Dec 31 | $66.9B | — | $5.7B | $1.6B | 2.4% | 1.81 | $13.7B | — | — | $3.1B | $1.6B |
| FY2022 · to Dec 31 | $68.8B | — | $6B | $5.3B | 7.7% | 6.30 | $13B | — | — | $3.3B | $1.6B |
| FY2021 · to Dec 31 | $68.7B | — | — | $6.9B | 10.0% | 7.65 | $12.3B | — | — | $4.3B | $1.6B |
| FY2020 · to Dec 31 | $67.8B | — | — | $5.4B | 8.0% | 5.68 | $11.6B | — | — | $1.2B | $1.7B |
Every number comes from METLIFE INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.